Acyclovir
- Product NDC
- 71335-1284
- 11-digit product format
- 713351284
- Labeler code
- 71335
- Product ID
- 71335-1284_ea778f5c-6b11-4245-9ca4-3fd8c4e0c962
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA210401
- Marketing category
- ANDA
- Marketing start
- 2018-05-04
- Marketing end
- 0000-00-00
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 71335-1284-1 | 71335128401 | 35 TABLET in 1 BOTTLE (71335-1284-1) | 35 tablet | 2018-05-04 | 0000-00-00 | No | No | Current |
| 71335-1284-2 | 71335128402 | 90 TABLET in 1 BOTTLE (71335-1284-2) | 90 tablet | 2019-12-06 | 0000-00-00 | No | No | Current |